This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Neurol. 1998;55:448.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS issue of the ARCHIVES and the April 22/29 issue of JAMA, attention is being directed toward important, emerging areas involving the treatment, prevention, and outcome predictors of stroke. A vital area of clinical research interest is posterior circulation ischemia and stroke. Our knowledge of posterior circulation disease has not developed as completely as that of anterior circulation. Therapy for vertebrobasilar disease has remained an area of intense controversy. Caplan¹ establishes perspective and cautions us in his lead editorial in this issue when he advises us how to proceed with the latest therapeutic modality, recombinant tissue-typplasminogen activator, in patients of the kind described by Grond et al² with vertebrobasilar stroke. Of considerable interest is that Grond et al² found a favorable outcome in the majority of their patients with vertebrobasilar stroke when they were treated with intravenous recombinant tissue-type plasminogen activator and heparin within 3 hours of symptom . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Vertebrobasilar Disease and Thrombolytic Treatment
Louis R. Caplan
Arch Neurol. 1998;55(4):450-451.
EXTRACT | FULL TEXT  

Potential Effects of Common Drugs on Stroke Recovery
Larry B. Goldstein
Arch Neurol. 1998;55(4):454-456.
ABSTRACT | FULL TEXT  

Treating Ischemic Stroke as an Emergency
Harold P. Adams, Jr
Arch Neurol. 1998;55(4):457-461.
ABSTRACT | FULL TEXT  

Early Intravenous Thrombolysis With Recombinant Tissue-type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Martin Grond, Jobst Rudolf, Susanne Schmülling, Christoph Stenzel, Michael Neveling, and Wolf-Dieter Heiss
Arch Neurol. 1998;55(4):466-469.
ABSTRACT | FULL TEXT  

Proximal Extracranial Vertebral Artery Disease in the New England Medical Center Posterior Circulation Registry
Robert J. Wityk, Hui M. Chang, Axel Rosengart, Wen-Chaing Han, L. Dana DeWitt, Michael S. Pessin, and Louis R. Caplan
Arch Neurol. 1998;55(4):470-478.
ABSTRACT | FULL TEXT  

Different Predictors of Neurological Worsening in Different Causes of Stroke
Haruko Yamamoto, Julien Bogousslavsky, and Guy van Melle
Arch Neurol. 1998;55(4):481-486.
ABSTRACT | FULL TEXT  

Prognostic Value of Proton Magnetic Resonance Spectroscopy in Ischemic Stroke
Francesco Federico, Isabella Laura Simone, Vincenzo Lucivero, Paolo Giannini, Giuseppe Laddomada, Domenico Maria Mezzapesa, and Carla Tortorella
Arch Neurol. 1998;55(4):489-494.
ABSTRACT | FULL TEXT